Sad week for our transplant community - Paul Terasaki - The father of microcytotoxicity test is no more. His obituary is here.
A-fib, CKD, hemorrhage - Sound familiar - Well, Twitter was buzzing with this controversial topic after Manish Sood published his analysis showing that decreasing eGFR and increasing albuminuria were independently associated with the risk of hemorrhage in CKD. Check it out in JASN. Other references to peruse
CKD in the pediatric population is often caused by monogenic mutations. This is explored by a new review in Nature Reviews Nephrology (Open Access).
The long term BENEFIT of Belatacept was published this week in NEJM. This generated a lot of discussion over the social media. Chiefly regarding the lack of Tacrolimus as the comparator. This will be a discussed in NephJC on February 22 and 23.
When patients initiate dialysis there is often disagreements between doctor and patients. New data from JAMA can be found here (Open Access).
John Daugirdas, who was part of both the HEMO and FHN RCTs writes a nice essay on the FHN Daily and Nocturnal Trials and points out the strengths, limitations and take home messages in a succinct manner.
